Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devic…
Medical - Devices
US, Marlborough [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 68.54 | 66.71 | 65.11 | 65.48 | 67.60 | 68.55 | 70.00 | 70.15 | 70.59 | 70.65 | 70.37 | 64.59 | 68.37 | 68.44 | 69.49 | |
| Profit Margin | -12.52 | -13.64 | 5.79 | -56.12 | -1.69 | 3.62 | -3.20 | 4.14 | 1.15 | 17.01 | 43.78 | -1.41 | 8.76 | 5.50 | 11.19 | |
| Operating Margin | -10.92 | -8.40 | 11.86 | -53.36 | 1.68 | 4.05 | -4.37 | 5.33 | 14.20 | 15.33 | 14.14 | -1.39 | 10.09 | 13.00 | 16.45 | |
|
EPS Growth
|
50.73 | -2.94 | 141.43 | -1,096.55 | 96.88 | 321.73 | -190.00 | 244.44 | -70.81 | 1,494.20 | 179.34 | -102.92 | 798.38 | -34.78 | 140.00 | |
| EPS USD | -68.00 | -70.00 | 29.00 | -289.00 | -9.02 | 20.00 | -18.00 | 26.00 | 7.59 | 121.00 | 338.00 | -9.88 | 69.00 | 45.00 | 108.00 | |
| Return on Assets (ROA) | -4.07 | -4.81 | 2.07 | -23.71 | -0.72 | 1.59 | -1.32 | 1.92 | 0.55 | 7.96 | 15.38 | -0.45 | 3.23 | 2.15 | 4.53 | |
| Return on Equity (ROE) | -8.33 | -9.43 | 3.88 | -59.21 | -1.85 | 3.90 | -3.78 | 5.15 | 1.48 | 19.15 | 33.87 | -0.91 | 6.26 | 3.97 | 8.26 | |
| Return on Invested Capital (ROIC) | -3.85 | -3.93 | 3.98 | -34.44 | 0.60 | 7.90 | -1.00 | 7.17 | 1.15 | 11.23 | 43.00 | -0.56 | 4.44 | 3.76 | 6.53 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 23.51 | 24.58 | 20.01 | 24.81 | 25.34 | 25.32 | 31.31 | 30.31 | 29.30 | 33.48 | 33.62 | 30.99 | 29.32 | 28.59 | 27.02 | |
| Debt/Equity | 48.11 | 48.14 | 37.53 | 61.95 | 64.84 | 62.28 | 89.83 | 81.45 | 79.56 | 80.57 | 74.06 | 62.24 | 56.86 | 52.82 | 49.23 | |
| Debt/EBITDA | -1,760.98 | 347.64 | 187.34 | 300.37 | 315.53 | 272.63 | 370.54 | 289.44 | 273.19 | 285.05 | 483.19 | 425.81 | 270.33 | 298.36 | 238.32 | |
|
Debt/Capitalization
|
32.48 | 32.50 | 27.29 | 38.25 | 39.34 | 38.38 | 47.32 | 44.89 | 44.31 | 44.62 | 42.55 | 38.36 | 36.25 | 34.56 | 32.99 | |
| Long-Term Debt/Capitalization | 32.47 | 30.40 | 27.27 | 38.23 | 39.32 | 36.06 | 47.31 | 44.60 | 35.01 | 35.38 | 38.97 | 38.33 | 35.60 | 34.51 | 31.73 | |
| Interest Debt per Share USD | 4.19 | 3.84 | 3.01 | 3.21 | 3.40 | 3.38 | 4.44 | 4.21 | 4.24 | 5.27 | 7.73 | 6.99 | 6.88 | 6.82 | 6.72 | |
| Debt Growth | -12.26 | -8.11 | -21.64 | -0.12 | -0.38 | 0.52 | 33.20 | -3.40 | 1.71 | 26.03 | 46.19 | -7.18 | -0.92 | -1.79 | 2.26 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 134.38 | 138.56 | 171.83 | 170.54 | 173.96 | 151.11 | 142.84 | 90.30 | 67.60 | 76.10 | 96.57 | 181.85 | 147.80 | 151.46 | 132.05 | |
| Quick Ratio | 103.94 | 104.29 | 120.31 | 120.65 | 124.78 | 108.99 | 101.03 | 63.67 | 48.53 | 53.94 | 64.12 | 145.15 | 110.13 | 102.37 | 81.69 | |
| Cash Ratio | 28.59 | 8.16 | 14.78 | 11.68 | 11.90 | 26.14 | 13.13 | 5.46 | 3.33 | 2.78 | 4.46 | 47.11 | 45.04 | 24.40 | 17.53 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 280.00 | 290.72 | 285.61 | 283.03 | 257.97 | 245.35 | 220.77 | 262.09 | 246.85 | 247.26 | 201.46 | 259.81 | 233.54 | 214.41 | 174.92 | |
| Receivables Turnover | 595.49 | 591.36 | 611.72 | 595.65 | 546.52 | 623.84 | 586.43 | 569.70 | 584.50 | 610.88 | 555.35 | 647.49 | 668.62 | 643.76 | 639.14 | |
| Payables Turnover | 1,215.09 | 1,412.50 | 1,309.85 | 1,078.45 | 940.65 | 885.88 | 1,073.21 | 559.96 | 502.08 | 826.07 | 586.90 | 684.21 | 473.55 | 464.39 | 461.25 | |
|
Asset Turnover
|
32.52 | 35.28 | 35.80 | 42.26 | 42.69 | 43.85 | 41.23 | 46.34 | 47.52 | 46.78 | 35.12 | 32.21 | 36.88 | 39.06 | 40.53 | |
| Fixed Turnover | 473.84 | 459.99 | 456.41 | 463.49 | 462.03 | 489.71 | 501.81 | 514.48 | 533.49 | 551.23 | 444.51 | 390.12 | 442.59 | 447.97 | 431.78 | |
| Coverage | ||||||||||||||||
| Interest Coverage | -219.66 | -166.92 | 321.71 | -1,481.99 | 37.04 | 138.43 | -115.14 | 191.85 | 561.14 | 624.90 | 320.93 | -38.23 | 351.61 | 350.85 | 884.15 | |
| Asset Coverage | 200 | 200 | 300 | 200 | 200 | 200 | 100 | 100 | 100 | 100 | 100 | 200 | 200 | 200 | 200 | |
| Cash Flow Coverage (CFGR) | 14.11 | 5.98 | 23.66 | 29.61 | 25.52 | 29.77 | 10.57 | 17.72 | 25.56 | 4.41 | 17.87 | 15.81 | 19.79 | 16.44 | 26.37 | |
| EBITDA Coverage | - - | 300 | 700 | 500 | 300 | 600 | 500 | 700 | 800 | 1,000 | 400 | 500 | 800 | 500 | 1,300 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 500 | -1,800 | -1,200 | -5,600 | |
| Time Interest Earned (TIE) | - - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 0.06 | 0.09 | 0.08 | 0.03 | |
| Earnings Yield | -7.80 | -9.13 | 5.53 | -50.08 | -0.75 | 1.55 | -0.95 | 1.19 | 0.30 | 3.49 | 7.50 | -0.28 | 1.69 | 1.05 | 1.88 | |
|
Price/Earnings (P/E)
|
-1,281.95 | -1,095.48 | 1,809.57 | -199.70 | -13,271.32 | 6,463.20 | -10,558.48 | 8,410.69 | 33,227.35 | 2,866.89 | 1,332.99 | -36,218.95 | 5,928.83 | 9,483.70 | 5,307.24 | |
| Price/Earnings Growth (PEG) | 25.27 | -372.46 | -12.79 | 0.18 | 136.99 | -20.09 | 55.57 | -34.41 | -469.26 | 1.92 | 7.43 | 351.90 | -7.43 | -272.66 | 37.91 | |
|
Price/Book (P/B)
|
106.82 | 103.28 | 70.29 | 118.25 | 245.58 | 252.18 | 399.28 | 433.46 | 492.89 | 549.06 | 451.47 | 330.83 | 371.29 | 376.67 | 438.48 | |
| Price/Tangible Book (P/TB) | 106.82 | 103.28 | 70.29 | 118.25 | 245.58 | 252.18 | 399.28 | 433.46 | 492.89 | 549.06 | 451.47 | 330.83 | 371.29 | 376.67 | 438.48 | |
| Price/Sales (P/S) | 160.48 | 149.46 | 104.70 | 112.07 | 224.81 | 233.83 | 337.50 | 348.02 | 381.92 | 487.69 | 583.61 | 511.52 | 519.17 | 521.97 | 593.71 | |
|
Price/Cash Flow (P/CF)
|
1,573.65 | 3,589.79 | 791.69 | 644.73 | 1,484.13 | 1,359.87 | 4,205.79 | 3,002.58 | 2,423.31 | 15,453.47 | 3,412.35 | 3,362.50 | 3,300.49 | 4,337.89 | 3,377.72 | |
| Price/Free CF (P/FCF) | 2,778.01 | 24,823.02 | 1,133.55 | 785.65 | 1,918.55 | 1,708.59 | 7,148.66 | 4,896.83 | 3,121.63 | -798,429.50 | 4,556.42 | 4,479.38 | 4,689.90 | 7,242.48 | 4,964.43 | |
| Price/Operating CF (P/OCF) | 1,573.65 | 3,589.79 | 791.69 | 644.73 | 1,484.13 | 1,359.87 | 4,205.79 | 3,002.58 | 2,423.31 | 15,453.47 | 3,412.35 | 3,362.50 | 3,300.49 | 4,337.89 | 3,377.72 |